HMGB1 as a potential biomarker and therapeutic target for severe COVID-19.
Chen R, Huang Y, Quan J, Liu J, Wang H, Billiar TR, Lotze MT, Zeh HJ, Kang R, Tang D.
Chen R, et al. Among authors: tang d.
Heliyon. 2020 Dec 7;6(12):e05672. doi: 10.1016/j.heliyon.2020.e05672. eCollection 2020 Dec.
Heliyon. 2020.
PMID: 33313438
Free PMC article.